Population-Adjusted Indirect Treatment Comparison with the outstandR Package in R
By: Nathan Green, Antonio Remiro-Azocar
Indirect treatment comparisons (ITCs) are essential in Health Technology Assessment (HTA) when head-to-head clinical trials are absent. A common challenge arises when attempting to compare a treatment with available individual patient data (IPD) against a competitor with only reported aggregate-level data (ALD), particularly when trial populations differ in effect modifiers. While methods such as Matching-Adjusted Indirect Comparison (MAIC) and Simulated Treatment Comparison (STC) exist to adjust for these cross-trial differences, software implementations have often been fragmented or limited in scope. This article introduces outstandR, an R package designed to provide a comprehensive and unified framework for population-adjusted indirect comparison (PAIC). Beyond standard weighting and regression approaches, outstandR implements advanced G-computation methods within both maximum likelihood and Bayesian frameworks, and Multiple Imputation Marginalization (MIM) to address non-collapsibility and missing data. By streamlining the workflow of covariate simulation, model standardization, and contrast estimation, outstandR enables robust and compatible evidence synthesis in complex decision-making scenarios.
Similar Papers
Arbitrated Indirect Treatment Comparisons
Machine Learning (Stat)
Finds the best medicine by comparing studies fairly.
Assessing the Impact of Covariate Distribution and Positivity Violation on Weighting-Based Indirect Comparisons: a Simulation Study
Methodology
Helps doctors compare treatments when data is tricky.
Methodological Advances and Challenges in Indirect Treatment Comparisons: A Review of International Guidelines and HAS TC Case Studies
Methodology
Helps drug reviews decide if new medicines work.